BENIGN PROSTATIC HYPERPLASIA (BPH): TREATMENT AND ANESTHETIC CONSIDERATIONS

Authors

  • Fernando Coutinho Felicio Graduado em Medicina Universidade do Oeste Paulista- UNOESTE, Presidente Prudente- SP
  • Luana Vasconcellos Mendonça Schiphorst Graduado em Medicina - Universidade Estácio de Sá
  • Bárbara Cirilo de Sá Coscia Médica pelo UNICEPLAC
  • Tulio ⁠ Saltarello Médico pela FEMA- ( fundação educacional do município de Assis-Sp )
  • Priscylla Lucena Santos Médica pela Unilago
  • Leandro Aparecido Irrazabal médico pela Universidade Federal do Pampa - UNIPAMPA
  • Pedro Henrique Barroso Aguiar Médico pelo Centro Universitário FAMETRO
  • Daniel Felipe Nobre Castiel Médico pela Universidade Salvador
  • Maria Helena Costa Borges Médica pela universidade Nilton lins
  • Letícia Franco Di Carvalho Vilela Médica pela Universidade de Ribeirão Preto
  • José María Duarte Médico pela Facultade de Medicina do Abc
  • Guilherme Zacarias Queiroz de Barros Braga Médico pela Universidade Federal do Maranhão
  • Gabriel Dutra Ramos Universidade Estácio de Sá Medicina
  • Gabriel Rozendo Mendonça Gomes Médico pela Universidade Nilton Lins

DOI:

https://doi.org/10.36557/2674-8169.2024v6n8p667-680

Keywords:

Prostatic Hyperplasia, Treatment, Anesthesia.

Abstract

Benign prostatic hyperplasia (BPH) is a common condition affecting elderly men, characterized by benign enlargement of the prostate that can lead to significant urinary symptoms. Therefore, management of this condition involves a variety of therapeutic options, from medications to surgical procedures. Objective: To explore the various therapeutic approaches to BPH and analyze the specific anesthetic considerations associated with these treatments.  Methodology: The Cochrane, Scielo and Medline databases were used, searching for articles published between 2022 and 2024, in Portuguese or English. Final Considerations: A multidisciplinary approach is essential for the effective management of BPH. In this way, a detailed understanding of treatment options, from drug therapies to surgical interventions, allows the personalization of care according to the individual needs of patients. Therefore, specific anesthetic considerations for each procedure are crucial to minimize risks and maximize patient safety and comfort. Furthermore, the continuous assessment of clinical outcomes and the identification of associated risk factors contribute to the continuous improvement of clinical practices.

Downloads

Download data is not yet available.

References

Bertolo, R. et al. Thulium laser enucleation of prostate versus laparoscopic trans-vesical simple prostatectomy in the treatment of large benign prostatic hyperplasia: head-to-head comparison. *International Braz J Urol*, 48(2), 328–335, 1 abr. 2022.

Cantiello, F. et al. Refining surgical strategies in ThuLEP for BPH: a propensity score matched comparison of En-bloc, three lobes, and two lobes techniques. *World J Urol*, p. 431–431, 2024.

Kazemi, R. et al. Evaluating the effectiveness of tranexamic acid administration in reducing bleeding in benign prostate hyperplasia patients underwent open prostatectomy: A double-blind randomized clinical trial. *Journal of Research in Medical Sciences*, 28(1), 8–8, 1 jan. 2023.

Manfredi, C. et al. Long-term functional outcomes and surgical retreatment after thulium laser enucleation of the prostate: A 10-year follow-up study. *International Braz J Urol*, 50, 309–318, 27 maio 2024.

Nobrega, O. T. et al. Serum levels of interleukin-2 differ between prostate cancer and benign prostatic hyperplasia. *Jornal Brasileiro de Patologia e Medicina Laboratorial*, 58, e4352022, 30 maio 2022.

Otaola-Arca, H. et al. A prospective randomized study comparing bipolar plasmakinetic transurethral resection of the prostate and monopolar transurethral resection of the prostate for the treatment of Benign Prostatic Hyperplasia: efficacy, sexual function, Quality of Life, and complications. *International Braz J Urol*, 47(1), 131–144, fev. 2021.

Peng, Y.-N. et al. Perioperative care based on roy adaptation model in elderly patients with benign prostatic hyperplasia: impact on psychological well-being, pain, and quality of life. *BMC Urology*, 23(1), 27 out. 2023.

Silva, M. H. A. da, & Souza, J. A. de. Vulnerabilidade de pacientes com hiperplasia prostática tratados com dutasterida e finasterida. *Revista Bioética*, 29(2), 394–400, jun. 2021.

Sfredo, L. R. et al. Comparative analysis between open transvesical and laparoscopic adenomectomy in the treatment of benigne prostatic hyperplasia in a tertiary hospital in Curitiba-PR: a retrospective study. *Revista do Colégio Brasileiro de Cirurgiões*, 50, e20233450, 14 abr. 2023.

Spirito, L. et al. Long-term functional outcomes and predictors of efficacy in thulium laser enucleation of the prostate (ThuLEP) for benign prostatic hyperplasia (BPH): a retrospective observational study. *J Basic Clin Physiol Pharmacol*, p. 169–174, 2024.

Downloads

Published

2024-08-05

How to Cite

Felicio, F. C., Schiphorst, L. V. M., Coscia , B. C. de S., Saltarello, T. ⁠, Santos, P. L., Irrazabal, L. A., Aguiar, P. H. B., Castiel , D. F. N., Borges, M. H. C., Vilela , L. F. D. C., Duarte , J. M., Braga , G. Z. Q. de B., Ramos , G. D., & Gomes, G. R. M. (2024). BENIGN PROSTATIC HYPERPLASIA (BPH): TREATMENT AND ANESTHETIC CONSIDERATIONS. Brazilian Journal of Implantology and Health Sciences, 6(8), 667–680. https://doi.org/10.36557/2674-8169.2024v6n8p667-680

Issue

Vol. 6 No. 8 (2024): BJIHS QUALIS B3 - FATOR DE IMPACTO SJIF 5.807

Section

Literature Review

License

Copyright (c) 2024 Fernando Coutinho Felicio, Luana Vasconcellos Mendonça Schiphorst, Bárbara Cirilo de Sá Coscia , Tulio ⁠ Saltarello, Priscylla Lucena Santos, Leandro Aparecido Irrazabal, Pedro Henrique Barroso Aguiar, Daniel Felipe Nobre Castiel , Maria Helena Costa Borges, Letícia Franco Di Carvalho Vilela , José María Duarte , Guilherme Zacarias Queiroz de Barros Braga , Gabriel Dutra Ramos , Gabriel Rozendo Mendonça Gomes

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors are copyright holders under a CCBY 4.0 license.